Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 4.0 | 5.0 |
Min SIP Amount | ₹500 | ₹100 |
Expense Ratio | 1.8 | 1.68 |
NAV | ₹101.75 | ₹221.81 |
Fund Started | 31 May 2007 | 20 Aug 2004 |
Fund Size | ₹11396.38 Cr | ₹17226.97 Cr |
Exit Load | Exit load of 1% if redeemed within 1 year | Exit load of 1% if redeemed within 1 year |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 7.37% | 17.27% |
3 Year | 16.88% | 23.16% |
5 Year | 26.80% | 31.05% |
1 Year
3 Year
5 Year
Equity | 94.81% | 83.37% |
Cash | 4.97% | 16.33% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
HDFC Bank Ltd. | 10.91% |
ICICI Bank Ltd. | 9.82% |
Bharti Airtel Ltd. | 5.93% |
Axis Bank Ltd. | 5.80% |
Reliance Industries Ltd. | 5.15% |
Sun Pharmaceutical Industries Ltd. | 4.87% |
Tata Consultancy Services Ltd. | 4.43% |
Cipla Ltd. | 4.43% |
Eternal Ltd. | 4.16% |
Maruti Suzuki India Ltd. | 3.54% |
Name | Assets |
---|---|
HDFC Bank Ltd. | 9.34% |
ICICI Bank Ltd. | 9.00% |
Axis Bank Ltd. | 8.70% |
Kotak Mahindra Bank Ltd. | 4.41% |
Maruti Suzuki India Ltd. | 4.18% |
SBI Life Insurance Company Ltd. | 4.04% |
Cipla Ltd. | 3.77% |
HCL Technologies Ltd. | 3.70% |
Bharti Airtel Ltd. | 3.22% |
Piramal Pharma Ltd. | 3.00% |
Name | Varun Sharma | Dhruv Muchhal |
Start Date | 01 Sep 2023 | 14 Sep 2023 |
Name
Start Date
Description | The scheme seeks to achieve capital appreciation through investing predominantly in Indian companies/sectors with high growth rates or potential. | The scheme seeks to generate long term capital appreciation/income by investing in equity & equity related instruments of up to 30 companies. |
Launch Date | 31 May 2007 | 20 Aug 2004 |
Description
Launch Date